The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2005
Filed:
Sep. 06, 2001
Stephen Todd, San Francisco, CA (US);
Angelo M. Delegeane, Milpitas, CA (US);
Ameena R. Gandhi, San Francisco, CA (US);
Danniel B. Nguyen, San Jose, CA (US);
April J. A. Hafalia, Daly City, CA (US);
Liam Kearney, San Francisco, CA (US);
Yan LU, Palo Alto, CA (US);
Ernestine A. Lee, Castro Valley, CA (US);
Narinder K. Chawla, Union City, CA (US);
Debopriya Das, Mountain View, CA (US);
Chandra S. Arvizu, San Jose, CA (US);
Monique G. Yao, Carmel, IN (US);
Deborah A. Kallick, Stanford, CA (US);
Vicki S. Elliott, San Jose, CA (US);
LI Ding, Creve Coeur, MO (US);
Henry Yue, Sunnyvale, CA (US);
Roopa M. Reddy, Fremont, CA (US);
Dyung Aina M. LU, San Jose, CA (US);
Jayalaxmi Ramkumar, Fremont, CA (US);
Junming Yang, San Jose, CA (US);
Catherine M. Tribouley, San Francisco, CA (US);
Neil Burford, Durham, CT (US);
Mariah R. Baughn, San Leandro, CA (US);
Preeti G. Lal, Santa Clara, CA (US);
Mark L. Borowsky, Redwood City, CA (US);
Farrah A. Khan, Des Plaines, IL (US);
Rajagopal Gururajan, San Jose, CA (US);
Y. Tom Tang, San Jose, CA (US);
Janice K. Au-young, Brisbane, CA (US);
Bridget A. Warren, Encinitas, CA (US);
Roberto Hernandez, Canterbury, GB;
Brendan M. Duggan, Sunnyvale, CA (US);
Stephen Todd, San Francisco, CA (US);
Angelo M. Delegeane, Milpitas, CA (US);
Ameena R. Gandhi, San Francisco, CA (US);
Danniel B. Nguyen, San Jose, CA (US);
April J. A. Hafalia, Daly City, CA (US);
Liam Kearney, San Francisco, CA (US);
Yan Lu, Palo Alto, CA (US);
Ernestine A. Lee, Castro Valley, CA (US);
Narinder K. Chawla, Union City, CA (US);
Debopriya Das, Mountain View, CA (US);
Chandra S. Arvizu, San Jose, CA (US);
Monique G. Yao, Carmel, IN (US);
Deborah A. Kallick, Stanford, CA (US);
Vicki S. Elliott, San Jose, CA (US);
Li Ding, Creve Coeur, MO (US);
Henry Yue, Sunnyvale, CA (US);
Roopa M. Reddy, Fremont, CA (US);
Dyung Aina M. Lu, San Jose, CA (US);
Jayalaxmi Ramkumar, Fremont, CA (US);
Junming Yang, San Jose, CA (US);
Catherine M. Tribouley, San Francisco, CA (US);
Neil Burford, Durham, CT (US);
Mariah R. Baughn, San Leandro, CA (US);
Preeti G. Lal, Santa Clara, CA (US);
Mark L. Borowsky, Redwood City, CA (US);
Farrah A. Khan, Des Plaines, IL (US);
Rajagopal Gururajan, San Jose, CA (US);
Y. Tom Tang, San Jose, CA (US);
Janice K. Au-Young, Brisbane, CA (US);
Bridget A. Warren, Encinitas, CA (US);
Roberto Hernandez, Canterbury, GB;
Brendan M. Duggan, Sunnyvale, CA (US);
Incyte Corporation, Wilmington, DE (US);
Abstract
The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.